The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Authors
Discussion
Loading...
Member takes
Implication
Consensus guideline updates diagnostic criteria and genetic profiles for lymphoid neoplasms, highlighting refined management for early-stage disease and targeted therapy.
Key Points
- To update the World Health Organization classification of lymphoid neoplasms based on recent clinical, pathological, and genetic discoveries.
- Convened an international consensus panel of hematopathologists, geneticists, and clinicians.
- Reviewed diagnostic criteria, provisional disease entities, and emerging genetic and molecular data across lymphoid neoplasms.
- Clarified the diagnostic criteria and clinical management pathways for early-stage lesions in lymphomagenesis.
- Introduced newly recognized provisional disease entities and refined definitions for established lymphoid neoplasm categories.
- Mapped emerging genetic and molecular alterations to their clinical correlates to guide precision diagnostic and targeted therapeutic strategies.
Cite This Study
Swerdlow et al. (2016) studied this question.